Today’s cough syrup could turn into tomorrow’s treatment for Parkinson’s disease. Recent research in the U.K. is the latest to suggest that a common ingredient in cough syrup, ambroxol, might be able ...

Parkinson's Disease (PD) is a progressive movement disorder of the nervous system that includes parts of your brain, spinal cord, and a complex network of nerves. A recent groundbreaking study of the ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric symptoms and potentially slowing cognitive decline in Parkinson's disease ...

Researchers at Lawson Research Institute are studying Ambroxol - a common cough medicine in Europe - as a potential treatment for dementia linked to Parkinson’s disease LONDON, Ont. – Dementia poses a ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests. Nearly half of those diagnosed with Parkinson’s ...

Please provide your email address to receive an email when new articles are posted on . Although a high number of adverse events were logged, most were mild to moderate in severity. The effects of ...

Share on Pinterest Could a cough medicine help treat Parkinson’s disease? Image credit: DEV IMAGES/Getty Images. Parkinson’s disease is a neurodegenerative disorder. Experts believe that both genetic ...

The Phase III trial will enroll over 300 people with Parkinson's disease, some of whom will receive the cough drug ambroxol. Reading time 3 minutes An important clinical trial for Parkinson’s disease ...

Ambroxol, a drug used in cough syrup to break up phlegm, may be worthy of further study as a neuroprotective compound in Parkinson's disease, AiM-PD trial results suggested. In a small, open-label, ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph’s Health Care London, are investigating whether Ambroxol - a cough medicine used safely for decades in Europe - can ...

A 12-month study conducted by researchers at Lawson Research Institute found that Ambroxol helped stabilise psychiatric symptoms, improved cognitive function, and protected against brain damage in ...